Bronx / New York / United States
Perrigo New York develops, manufactures, and markets generic topical drugs including prescription and private label over-the-counter products, as well as private label cosmetics and grooming products. The company has a long-standing history of manufacturing generic topicals that sell to all major trade classes. The organization s research and development departments focuses on topicals that encompass many forms of dermatological products, such as creams, ointments, lotions, gels, solutions, suppositories and unit doses. The pipeline also contains delivery systems including nasal sprays, foams, transdermal hormones and various other types of products. Perrigo New York has eight ANDAs under FDA review, pending approval and has obtained FDA approvals for Ketoconazole Shampoo 2%, Desoximetasone Cream USP 0.25%, Promethazine Supp. 12.5 mg & 25 mg, Permethrin Cream 5%, Ammonium Lactate Cream 12%, Mometasone Ointment 0.1%, Mupirocin Ointment 2% and Betamethasone DP Augmented Cream 0.05%. The company maintains its corporate offices and a 350,000 square-food facility in New York.
